Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$7.47
+8.1%
$9.41
$2.09
$14.84
$489.89M0.053.66 million shs2.34 million shs
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
$6.58
+1.5%
$6.20
$3.33
$7.05
$1.23B1.321.81 million shs1.73 million shs
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
$18.21
$11.74
$19.90
$1.67B1.03658,571 shs65,804 shs
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
$142.93
+0.9%
$150.95
$130.27
$161.41
$1.09B0.8528,770 shs18,923 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
+8.10%-1.06%-17.73%-25.45%+29.02%
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
+1.54%+4.03%+2.17%+9.03%+54.10%
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
0.00%0.00%0.00%0.00%0.00%
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
+0.88%-1.45%-6.69%-6.56%-9.50%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
1.5967 of 5 stars
3.32.00.00.03.21.70.0
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
3.2053 of 5 stars
2.32.00.04.92.31.70.6
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
N/AN/AN/AN/AN/AN/AN/AN/A
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.67
Moderate Buy$15.00100.80% Upside
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
2.50
Moderate Buy$7.5013.98% Upside
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
N/AN/AN/AN/A
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
0.00
N/A$192.1334.42% Upside

Current Analyst Ratings

Latest ALT, BKD, CLI, FBT, and ID8 Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$9.00
4/1/2024
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
3/28/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
2/13/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
1/24/2024
Altimmune, Inc. stock logo
ALT
Altimmune
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$13.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$430K1,231.51N/AN/A$2.75 per share2.72
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
$3.02B0.41$0.87 per share7.59$2.15 per share3.06
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
$313.56M0.00N/AN/A$17.55 per share0.00
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
-$189.01M-$0.84N/AN/AN/A-6.27%-44.01%-3.75%5/13/2024 (Estimated)
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
-$51.39M-$0.41N/A0.002.58-8.54%-7.28%-2.31%N/A
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/A16.52N/AN/AN/AN/AN/A

Latest ALT, BKD, CLI, FBT, and ID8 Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/27/2024Q4 2023
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.33+$0.02-$0.12N/A$0.04 million
2/20/2024Q4 2023
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
-$0.19-$0.40-$0.21-$0.40N/A$754.48 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
N/AN/AN/AN/AN/A
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
N/AN/AN/AN/AN/A
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
17.26
17.26
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
9.40
0.80
0.80
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
1.61
0.72
0.72
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5970.89 million67.99 millionOptionable
Brookdale Senior Living Inc. stock logo
BKD
Brookdale Senior Living
25,200189.34 million186.50 millionOptionable
Mack-Cali Realty Co. stock logo
CLI
Mack-Cali Realty
2,01890.95 million85.76 millionOptionable
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/A7.60 millionN/ANot Optionable

ALT, BKD, CLI, FBT, and ID8 Headlines

SourceHeadline
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
zacks.com - April 9 at 7:21 AM
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
zacks.com - April 1 at 7:21 AM
First Trust NYSE Arca Biotechnology Index Fund (FBT)First Trust NYSE Arca Biotechnology Index Fund (FBT)
finance.yahoo.com - March 31 at 4:22 AM
Closing Bell: First Trust NYSE Arca Biotechnology ETF up on Friday (FBT)Closing Bell: First Trust NYSE Arca Biotechnology ETF up on Friday (FBT)
theglobeandmail.com - January 6 at 1:41 PM
Closing Bell: First Trust NYSE Arca Biotechnology ETF flat on Friday (FBT)Closing Bell: First Trust NYSE Arca Biotechnology ETF flat on Friday (FBT)
theglobeandmail.com - January 6 at 1:41 PM
First Trust Dynamic Europe Equity Income Fund Declares its Monthly Common Share Distribution of $0.07 Per Share for NovemberFirst Trust Dynamic Europe Equity Income Fund Declares its Monthly Common Share Distribution of $0.07 Per Share for November
benzinga.com - October 23 at 5:34 PM
NYSE Arca Major Market IndexNYSE Arca Major Market Index
wsj.com - September 29 at 12:33 AM
FBT First Trust NYSE Arca Biotechnology Index Fund ETFFBT First Trust NYSE Arca Biotechnology Index Fund ETF
seekingalpha.com - April 27 at 10:23 AM
NYSE Arca Securities Broker/Dealer IndexNYSE Arca Securities Broker/Dealer Index
wsj.com - March 17 at 5:39 PM
NYSE Arca Gold BUGS IndexNYSE Arca Gold BUGS Index
wsj.com - March 11 at 6:50 PM
First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT: FBT)First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT: FBT)
fool.com - October 22 at 3:06 AM
First Trust Energy Infrastructure Fund Issues Notice Regarding October 2022 DistributionFirst Trust Energy Infrastructure Fund Issues Notice Regarding October 2022 Distribution
markets.buffalonews.com - October 17 at 4:24 PM
2 Health Care And Biotech ETFs Poised For Robust Returns This Year2 Health Care And Biotech ETFs Poised For Robust Returns This Year
investing.com - June 9 at 5:09 AM
Best Biotech ETFs for Q3 2022Best Biotech ETFs for Q3 2022
finance.yahoo.com - June 4 at 1:51 AM
Best Biotech ETFs for Q2 2022Best Biotech ETFs for Q2 2022
finance.yahoo.com - February 25 at 10:32 PM
Get Ready for a Biotech ETF ComebackGet Ready for a Biotech ETF Comeback
finance.yahoo.com - February 20 at 9:07 PM
Biotech ETFs plunge in the first month of 2022, some down nearly 30%Biotech ETFs plunge in the first month of 2022, some down nearly 30%
seekingalpha.com - January 27 at 6:05 PM
FBT Makes Bullish Cross Above Critical Moving AverageFBT Makes Bullish Cross Above Critical Moving Average
nasdaq.com - December 23 at 7:28 PM
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
msn.com - October 25 at 7:43 AM
Why ETFs may be the best way to bet on the future of biotechWhy ETFs may be the best way to bet on the future of biotech
theglobeandmail.com - October 12 at 6:51 AM
FBTs Holdings Imply 19% Gain PotentialFBT's Holdings Imply 19% Gain Potential
nasdaq.com - September 2 at 5:10 PM
FBT Crosses Below Key Moving Average LevelFBT Crosses Below Key Moving Average Level
nasdaq.com - August 16 at 4:51 PM
How The Pieces Add Up: FBT Targets $208How The Pieces Add Up: FBT Targets $208
nasdaq.com - August 12 at 2:34 PM
Q2 Growth Nothing Short Of Virtuous: EconomistQ2 Growth 'Nothing Short Of Virtuous': Economist
msn.com - July 29 at 7:14 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Altimmune logo

Altimmune

NASDAQ:ALT
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Brookdale Senior Living logo

Brookdale Senior Living

NYSE:BKD
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding, single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment also operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It also manages communities on behalf of others. Brookdale Senior Living Inc. was incorporated in 2005 and is headquartered in Brentwood, Tennessee.
Mack-Cali Realty logo

Mack-Cali Realty

NYSE:CLI
Mack-Cali Realty Corp. is a real estate investment trust, which owns and operates a real estate portfolio comprised predominantly of Class A office and office flex properties located primarily in the Northeast. It operates through the following two segments: Commercial and Other Real Estate, and Multi-Family Real Estate and Services. The Commercial and Other Real Estate and Multi-Family Real Estate Portfolio segments provides leasing, property management, acquisition, development, construction, and tenant-related services. The company was founded in 1949 and is headquartered in Jersey City, NJ.
First Trust NYSE Arca Biotechnology Index Fund logo

First Trust NYSE Arca Biotechnology Index Fund

NYSEARCA:FBT
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.